EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS073-07401 
Organism
Homo sapiens 
Tissue/cell
GM19238 
Coordinate
chr19:16254580-16255670 
Target genes
Number: 5             
NameEnsembl ID
TF binding sites/motifs
Number: 3             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
NFAT5MA0606.1chr19:16254744-16254754AATGGAAAAT-6.02
NFATC1MA0624.1chr19:16254744-16254754AATGGAAAAT-6.02
NFATC3MA0625.1chr19:16254744-16254754AATGGAAAAT-6.02
Number of super-enhancer constituents: 3             
IDCoordinateTissue/cell
SE_09640chr19:16251336-16262834CD14
SE_44018chr19:16253563-16258783MM1S
SE_67337chr19:16253563-16258783MM1S
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr191625458916254800
Enhancer Sequence
CCAGGTATGT GACCCAAGAG CCTCAGCCCT CGAGGAGACA GAACGTGGGG GCTGGGCTAG 60
GCCAGAAGGA GGGACAGGGC TAGTGGGGCC TGGGGTGGCA GGAGGGATTT TCTAGGGGCA 120
TGGGGGAGAG CTTCGTGGAG GAGGGGGTAT TTGTGGTGAC CACAAATGGA AAATGGAGCT 180
GGAGTTAGGG AAAAGGGGGT CTTGGCAAGA CAACAGCATG AGCAAAGGTA TGGAGAGGCA 240
AGAGAGAGAG AGCAAGGATG TCTTTAGGTC TAGAATGTGG GTAGCGGGGA AGTAGAGGAG 300
GCTCCCAGGC CAGGGTCAGG AGCTTGAATT TGAGCATGCG GTCTTTCATC ACTAGATAGC 360
TGTTCACCAG CAAAGACCCT TGCACCCTCC TCTGTGCCAG GCCAGCACCA GGACACAGAA 420
AAAAACAACA ACACAGGAAC CTAGCCCTAA GCCCTGATCC CTAGGAGGCC CTCAGGCTGG 480
TGGAGACAGA GCAAGATAAA GACACTCTAG CTCCATGGAG TCATGGCTGG ACCAGAGAGA 540
GGAACAGGGG GGAACGTTGG GGACAGAGAG GGGTGCCAGG GTGTTGTCTG GGGGGAGATG 600
CAGGAAAGCT GCCTGGAGGA GGGGACATTT TTACTGGGTT TTGAAGGATA AATAGGAGCT 660
CTTCCAAGTA AAAAAAAAGA ATAAGCCTGT AAACATTACC CCATGATAGG TCACAACTGG 720
ATTCATGAAT ATTGTATATA TATCTCTATA TATACACAGT GCTAGCTAAA CTTTCCTAGG 780
TAAATATCAT TATTCCCAAA TTAAAGACAG AAATACAGGG ACAGAGAGCC ATTAAGTGAC 840
TTATCTGAGG TCACACAGCG GCTAAGTGGG CGAGCTAGGG TTTGAACCCA GGCCATCTGG 900
GTCGAATTCT AGGCTCTTTT TTTTTTTTTT TTTTTTTTTT GAGACGGAGT CTTGCTCTGT 960
CGCCCAGGCT GGAGTGCAGT GGCTCGATCT CAGCTCACTG CAAGCTCTGC CTCCCGAGTT 1020
CACGCCATTC TCCTGCCTCA GCCTCCCAAG TAGCTGAGAC TACAGGCGCC CGCCACCACA 1080
CCCAGCTAAT 1090